Web Results

Gemtuzumab ozogamicin - Wikipedia

en.wikipedia.org/wiki/Gemtuzumab_ozogamicin

Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody- drug conjugate) that was used to treat acute myelogenous leukemia from 2000 to  ...

Gemtuzumab Ozogamicin Voluntarily Withdrawn from U.S. Markets ...

www.cancer.gov/about-cancer/treatment/drugs/fda-gemtuzumab-ozogamicin

Jun 24, 2010 ... Pfizer, Inc., in agreement with the FDA, announced their discontinuing commercial marketing of gemtuzumab ozogamicin (Mylotarg) as of ...

Gemtuzumab Ozogamicin - Drug Information - Chemocare

chemocare.com/chemotherapy/drug-info/gemtuzumab-ozogamicin.aspx

Mylotarg is the trade name for gemtuzumab ozogamicin. In some cases, health care professionals may use the trade name mylotarg when referring to the ...

Gemtuzumab (Mylotarg®) - Cancer Information - Macmillan Cancer ...

www.macmillan.org.uk/cancerinformation/cancertreatment/treatmenttypes/biologicaltherapies/monoclonalantibodies/gemtuzumab.aspx

Information about the monoclonal antibody gemtuzumab (Mylotarg®), which is mainly used as part of research trials to treat some types of acute myeloid ...

Gemtuzumab ozogamicin (Mylotarg®; Pfizer/Wyeth) ADC Review

adcreview.com/gemtuzumab-ozogamicin-mylotarg/

Jul 19, 2015 ... Gemtuzumab ozogamicin (Mylotarg®; Pfizer/Wyeth-Ayerst Laboratories) is a recombinant, humanized anti-CD33 monoclonal antibody (IgG4 κ ...

Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable ...

www.bloodjournal.org/content/121/24/4838

Gemtuzumab ozogamicin (GO) consists of a humanized anti-CD33 monoclonal antibody conjugated with calicheamicin, a potent antitumor anthracycline ...

Gemtuzumab ozogamicin (Mylotarg) in children with refractory or ...

www.ncbi.nlm.nih.gov/pubmed/15249716

BACKGROUND: Gemtuzumab ozogamicin (GO) is an immunoconjugate consisting of the CD33 antibody and calicheamicin, a potent cytotoxic agent.

Mylotarg - FDA prescribing information, side effects and uses

www.drugs.com/pro/mylotarg.html

Mylotarg® (gemtuzumab ozogamicin for Injection) is a chemotherapy agent composed of a recombinant humanized IgG4, kappa antibody conjugated with a  ...

Gemtuzumab Ozogamicin: Time to Resurrect?: Journal of Clinical ...

ascopubs.org/doi/full/10.1200/jco.2012.43.0132

On May 17, 2000, the US Food and Drug Administration (FDA) granted accelerated approval for the use of gemtuzumab ozogamicin (GO) in older patients (age ...

Safety Alerts for Human Medical Products > Mylotarg (gemtuzumab ...

www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm216458.htm

Mylotarg (gemtuzumab ozogamicin): Market Withdrawal. Audience: Oncology, Hematology. [Posted 06/21/2010]. ISSUE: FDA notified healthcare professionals  ...